HEADER IMMUNE SYSTEM 28-AUG-23 8U03 TITLE CRYSTAL STRUCTURE OF NON-GLYCOSYLATED 10E8-GT10.1 SCAFFOLD IN COMPLEX TITLE 2 WITH A HUMAN 10E8 NGS PRECURSOR (10E8-NGS-03) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 10E8-NGS-03 FAB HEAVY CHAIN; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 10E8-NGS-03 FAB LIGHT CHAIN; COMPND 7 CHAIN: L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: 10E8-GT10.1 EPITOPE SCAFFOLD; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: FREESTYLE 293F; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHLSEC; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: FREESTYLE 293F; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PHLSEC; SOURCE 21 MOL_ID: 3; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606; SOURCE 25 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 26 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 28 EXPRESSION_SYSTEM_CELL_LINE: FREESTYLE 293F; SOURCE 29 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 30 EXPRESSION_SYSTEM_PLASMID: PHLSEC KEYWDS VACCINE, BROADLY NEUTRALIZING ANTIBODY, HIV, GP41, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.IRIMIA,I.A.WILSON REVDAT 3 16-OCT-24 8U03 1 REMARK REVDAT 2 19-JUN-24 8U03 1 JRNL REVDAT 1 12-JUN-24 8U03 0 JRNL AUTH T.SCHIFFNER,I.PHUNG,R.RAY,A.IRIMIA,M.TIAN,O.SWANSON,J.H.LEE, JRNL AUTH 2 C.D.LEE,E.MARINA-ZARATE,S.Y.CHO,J.HUANG,G.OZOROWSKI, JRNL AUTH 3 P.D.SKOG,A.M.SERRA,K.RANTALAINEN,J.D.ALLEN,S.BABOO, JRNL AUTH 4 O.L.RODRIGUEZ,S.HIMANSU,J.ZHOU,J.HURTADO,C.T.FLYNN, JRNL AUTH 5 K.MCKENNEY,C.HAVENAR-DAUGHTON,S.SAHA,K.SHIELDS,S.SCHULZE, JRNL AUTH 6 M.L.SMITH,C.H.LIANG,L.TOY,S.PECETTA,Y.C.LIN,J.R.WILLIS, JRNL AUTH 7 F.SESTERHENN,D.W.KULP,X.HU,C.A.COTTRELL,X.ZHOU,J.RUIZ, JRNL AUTH 8 X.WANG,U.NAIR,K.H.KIRSCH,H.L.CHENG,J.DAVIS,O.KALYUZHNIY, JRNL AUTH 9 A.LIGUORI,J.K.DIEDRICH,J.T.NGO,V.LEWIS,N.PHELPS,R.D.TINGLE, JRNL AUTH10 S.SPENCER,E.GEORGESON,Y.ADACHI,M.KUBITZ,S.ESKANDARZADEH, JRNL AUTH11 M.A.ELSLIGER,R.R.AMARA,E.LANDAIS,B.BRINEY,D.R.BURTON, JRNL AUTH12 D.G.CARNATHAN,G.SILVESTRI,C.T.WATSON,J.R.YATES 3RD, JRNL AUTH13 J.C.PAULSON,M.CRISPIN,G.GRIGORYAN,A.B.WARD,D.SOK,F.W.ALT, JRNL AUTH14 I.A.WILSON,F.D.BATISTA,S.CROTTY,W.R.SCHIEF JRNL TITL VACCINATION INDUCES BROADLY NEUTRALIZING ANTIBODY PRECURSORS JRNL TITL 2 TO HIV GP41. JRNL REF NAT.IMMUNOL. V. 25 1073 2024 JRNL REFN ESSN 1529-2916 JRNL PMID 38816615 JRNL DOI 10.1038/S41590-024-01833-W REMARK 2 REMARK 2 RESOLUTION. 2.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 27793 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1389 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.4000 - 5.8400 0.99 2878 152 0.2183 0.2226 REMARK 3 2 5.8400 - 4.6400 0.99 2778 146 0.1875 0.2067 REMARK 3 3 4.6400 - 4.0600 1.00 2747 144 0.1655 0.1942 REMARK 3 4 4.0600 - 3.6900 1.00 2719 143 0.2012 0.2293 REMARK 3 5 3.6900 - 3.4200 1.00 2739 145 0.2461 0.3172 REMARK 3 6 3.4200 - 3.2200 0.99 2700 142 0.2542 0.3224 REMARK 3 7 3.2200 - 3.0600 1.00 2700 141 0.3031 0.3419 REMARK 3 8 3.0600 - 2.9300 0.99 2670 140 0.3462 0.3937 REMARK 3 9 2.9300 - 2.8100 0.90 2417 127 0.3404 0.4236 REMARK 3 10 2.8100 - 2.7200 0.76 2056 109 0.3773 0.4898 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.505 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.194 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 86.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 106.9 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4760 REMARK 3 ANGLE : 0.533 6478 REMARK 3 CHIRALITY : 0.043 719 REMARK 3 PLANARITY : 0.004 829 REMARK 3 DIHEDRAL : 16.859 1715 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 23.6436 16.9496 29.9390 REMARK 3 T TENSOR REMARK 3 T11: 0.6914 T22: 0.6782 REMARK 3 T33: 0.7809 T12: 0.0327 REMARK 3 T13: -0.0207 T23: 0.0337 REMARK 3 L TENSOR REMARK 3 L11: 0.5318 L22: 0.3825 REMARK 3 L33: 1.2876 L12: 0.3811 REMARK 3 L13: 0.2720 L23: 0.3753 REMARK 3 S TENSOR REMARK 3 S11: 0.0890 S12: 0.2515 S13: 0.0167 REMARK 3 S21: 0.0524 S22: -0.1296 S23: -0.0430 REMARK 3 S31: 0.0858 S32: -0.2303 S33: -0.0016 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8U03 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1000277022. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27880 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.720 REMARK 200 RESOLUTION RANGE LOW (A) : 34.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.72 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 1.00000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M IMIDAZOLE PH 8, 40% PEG400, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.79950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.71600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.60900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 87.71600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.79950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.60900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG L 189 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS H 43 -168.48 -124.13 REMARK 500 PRO H 62 21.51 -75.51 REMARK 500 VAL H 63 -22.69 -141.46 REMARK 500 SER H 144 54.32 -108.81 REMARK 500 ASP H 156 66.24 60.78 REMARK 500 PRO H 214 -9.59 -58.27 REMARK 500 PRO L 39 -72.27 -30.06 REMARK 500 ASN L 51 67.11 -160.64 REMARK 500 SER L 55 -103.99 20.43 REMARK 500 GLU L 82 87.72 -63.42 REMARK 500 SER L 92 -83.14 42.13 REMARK 500 SER L 93 -94.32 -157.99 REMARK 500 HIS L 94B -106.76 -126.70 REMARK 500 LEU L 94C -43.85 -162.87 REMARK 500 LEU L 106 -85.82 -74.09 REMARK 500 ASP L 151 -88.22 55.77 REMARK 500 SER L 152 18.79 -142.23 REMARK 500 GLN L 167 -162.84 -104.85 REMARK 500 ASN L 170 -6.23 69.33 REMARK 500 PRO C 82 -158.60 -70.33 REMARK 500 REMARK 500 REMARK: NULL DBREF 8U03 H 1 226 PDB 8U03 8U03 1 226 DBREF 8U03 L 3 210 PDB 8U03 8U03 3 210 DBREF 8U03 C 1 155 PDB 8U03 8U03 1 155 SEQRES 1 H 232 GLU VAL GLN LEU VAL GLU SER GLY GLY ALA LEU VAL LYS SEQRES 2 H 232 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 232 PHE THR PHE SER ASN ALA TRP MET SER TRP VAL ARG GLN SEQRES 4 H 232 ALA PRO GLY LYS GLY LEU GLU TRP VAL GLY ARG ILE LYS SEQRES 5 H 232 SER LYS THR ASP GLY GLY THR THR ASP TYR ALA ALA PRO SEQRES 6 H 232 VAL LYS GLY ARG PHE THR ILE SER ARG ASP ASP SER LYS SEQRES 7 H 232 ASN THR LEU TYR LEU GLN MET ASN SER LEU LYS THR GLU SEQRES 8 H 232 ASP THR ALA VAL TYR TYR CYS THR THR VAL GLN THR TYR SEQRES 9 H 232 TYR ASP PHE TRP SER GLY TYR TYR GLN GLN HIS TYR TYR SEQRES 10 H 232 PHE ASP TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 11 H 232 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 12 H 232 PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU SEQRES 13 H 232 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 14 H 232 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 15 H 232 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 16 H 232 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 17 H 232 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 18 H 232 ASN THR LYS VAL ASP LYS ARG VAL GLU PRO LYS SEQRES 1 L 211 GLU LEU THR GLN ASP PRO ALA VAL SER VAL ALA LEU GLY SEQRES 2 L 211 GLN THR VAL ARG ILE THR CYS GLN GLY ASP SER LEU ARG SEQRES 3 L 211 SER TYR TYR ALA SER TRP TYR GLN GLN LYS PRO GLY GLN SEQRES 4 L 211 ALA PRO VAL LEU VAL ILE TYR GLY LYS ASN ASN ARG PRO SEQRES 5 L 211 SER GLY ILE PRO ASP ARG PHE SER GLY SER SER SER GLY SEQRES 6 L 211 ASN THR ALA SER LEU THR ILE THR GLY ALA GLN ALA GLU SEQRES 7 L 211 ASP GLU ALA ASP TYR TYR CYS ASN SER ARG ASP SER SER SEQRES 8 L 211 GLY ASN HIS LEU TRP VAL PHE GLY GLY GLY THR LYS LEU SEQRES 9 L 211 THR VAL LEU GLY GLN PRO LYS ALA ALA PRO SER VAL THR SEQRES 10 L 211 LEU PHE PRO PRO SER SER GLU GLU LEU GLN ALA ASN LYS SEQRES 11 L 211 ALA THR LEU VAL CYS LEU ILE SER ASP PHE TYR PRO GLY SEQRES 12 L 211 ALA VAL THR VAL ALA TRP LYS ALA ASP SER SER PRO VAL SEQRES 13 L 211 LYS ALA GLY VAL GLU THR THR THR PRO SER LYS GLN SER SEQRES 14 L 211 ASN ASN LYS TYR ALA ALA SER SER TYR LEU SER LEU THR SEQRES 15 L 211 PRO GLU GLN TRP LYS SER HIS ARG SER TYR SER CYS GLN SEQRES 16 L 211 VAL THR HIS GLU GLY SER THR VAL GLU LYS THR VAL ALA SEQRES 17 L 211 PRO THR GLU SEQRES 1 C 155 GLU VAL THR GLN GLU ASP ILE ILE ARG ALA LEU ALA SER SEQRES 2 C 155 PRO LEU ILE LYS ASP GLY MET VAL ASP GLU ASP PHE ALA SEQRES 3 C 155 GLU TYR VAL ILE GLU ARG GLU LYS ARG SER PRO THR GLY SEQRES 4 C 155 LEU GLN VAL LYS GLY VAL GLY VAL ALA ILE PRO HIS THR SEQRES 5 C 155 LEU GLY GLU TYR VAL ARG ASP ASN ALA ILE SER VAL GLY SEQRES 6 C 155 ILE LEU ASP LYS PRO VAL ASN PHE GLU GLY TRP TYR GLN SEQRES 7 C 155 SER PRO ASP PRO VAL PRO VAL ARG VAL VAL PHE MET LEU SEQRES 8 C 155 ALA GLY ARG THR TRP ASP ASP ILE VAL ASN VAL LEU LYS SEQRES 9 C 155 TRP ILE LYS ASP VAL ILE LEU ASP GLU GLU PHE MET LYS SEQRES 10 C 155 ARG LEU LEU THR MET SER ASP GLU GLU ILE TYR ARG GLN SEQRES 11 C 155 ILE TYR THR ARG ILE SER LYS ALA PRO GLY MET ARG GLY SEQRES 12 C 155 ILE HIS PHE LYS ARG GLU TYR VAL ARG HIS LEU GLY HET 1PE L 301 16 HET IMD L 302 5 HETNAM 1PE PENTAETHYLENE GLYCOL HETNAM IMD IMIDAZOLE HETSYN 1PE PEG400 FORMUL 4 1PE C10 H22 O6 FORMUL 5 IMD C3 H5 N2 1+ FORMUL 6 HOH *6(H2 O) HELIX 1 AA1 THR H 28 ALA H 32 5 5 HELIX 2 AA2 SER H 52A GLY H 54 5 5 HELIX 3 AA3 LYS H 83 THR H 87 5 5 HELIX 4 AA4 SER H 199 LEU H 201 5 3 HELIX 5 AA5 LYS H 213 ASN H 216 5 4 HELIX 6 AA6 ASP L 25 SER L 29 5 5 HELIX 7 AA7 GLN L 78 GLU L 82 5 5 HELIX 8 AA8 SER L 121 ALA L 127 1 7 HELIX 9 AA9 THR L 181 LYS L 186 1 6 HELIX 10 AB1 THR C 3 ASP C 18 1 16 HELIX 11 AB2 ASP C 24 SER C 36 1 13 HELIX 12 AB3 THR C 95 LEU C 111 1 17 HELIX 13 AB4 ASP C 112 LEU C 120 1 9 HELIX 14 AB5 SER C 123 LYS C 137 1 15 HELIX 15 AB6 LYS C 147 GLU C 149 5 3 SHEET 1 AA1 4 GLN H 3 SER H 7 0 SHEET 2 AA1 4 LEU H 18 SER H 25 -1 O ALA H 23 N VAL H 5 SHEET 3 AA1 4 THR H 77 MET H 82 -1 O LEU H 80 N LEU H 20 SHEET 4 AA1 4 PHE H 67 ASP H 72 -1 N SER H 70 O TYR H 79 SHEET 1 AA2 6 LEU H 11 VAL H 12 0 SHEET 2 AA2 6 THR H 119 VAL H 123 1 O THR H 122 N VAL H 12 SHEET 3 AA2 6 ALA H 88 TYR H 98 -1 N ALA H 88 O VAL H 121 SHEET 4 AA2 6 TRP H 33 GLN H 39 -1 N GLN H 39 O VAL H 89 SHEET 5 AA2 6 LEU H 45 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 AA2 6 THR H 57 TYR H 59 -1 O ASP H 58 N ARG H 50 SHEET 1 AA3 4 LEU H 11 VAL H 12 0 SHEET 2 AA3 4 THR H 119 VAL H 123 1 O THR H 122 N VAL H 12 SHEET 3 AA3 4 ALA H 88 TYR H 98 -1 N ALA H 88 O VAL H 121 SHEET 4 AA3 4 HIS H 109 TRP H 115 -1 O HIS H 109 N TYR H 98 SHEET 1 AA4 4 SER H 132 LEU H 136 0 SHEET 2 AA4 4 THR H 147 TYR H 157 -1 O LYS H 155 N SER H 132 SHEET 3 AA4 4 TYR H 188 PRO H 197 -1 O TYR H 188 N TYR H 157 SHEET 4 AA4 4 VAL H 175 THR H 177 -1 N HIS H 176 O VAL H 193 SHEET 1 AA5 4 SER H 132 LEU H 136 0 SHEET 2 AA5 4 THR H 147 TYR H 157 -1 O LYS H 155 N SER H 132 SHEET 3 AA5 4 TYR H 188 PRO H 197 -1 O TYR H 188 N TYR H 157 SHEET 4 AA5 4 VAL H 181 LEU H 182 -1 N VAL H 181 O SER H 189 SHEET 1 AA6 3 THR H 163 TRP H 166 0 SHEET 2 AA6 3 TYR H 206 HIS H 212 -1 O ASN H 211 N THR H 163 SHEET 3 AA6 3 THR H 217 VAL H 223 -1 O VAL H 219 N VAL H 210 SHEET 1 AA7 4 THR L 5 GLN L 6 0 SHEET 2 AA7 4 VAL L 18 GLN L 23 -1 O GLN L 23 N THR L 5 SHEET 3 AA7 4 THR L 69 ILE L 74 -1 O ALA L 70 N CYS L 22 SHEET 4 AA7 4 PHE L 61 SER L 66 -1 N SER L 62 O THR L 73 SHEET 1 AA8 5 ALA L 9 VAL L 12 0 SHEET 2 AA8 5 THR L 101 VAL L 105 1 O THR L 104 N VAL L 10 SHEET 3 AA8 5 ASP L 84 SER L 89 -1 N TYR L 85 O THR L 101 SHEET 4 AA8 5 SER L 33 GLN L 37 -1 N GLN L 37 O ASP L 84 SHEET 5 AA8 5 VAL L 44 ILE L 47 -1 O ILE L 47 N TRP L 34 SHEET 1 AA9 4 ALA L 9 VAL L 12 0 SHEET 2 AA9 4 THR L 101 VAL L 105 1 O THR L 104 N VAL L 10 SHEET 3 AA9 4 ASP L 84 SER L 89 -1 N TYR L 85 O THR L 101 SHEET 4 AA9 4 VAL L 96 PHE L 97 -1 O VAL L 96 N SER L 89 SHEET 1 AB1 4 SER L 114 PHE L 118 0 SHEET 2 AB1 4 ALA L 130 PHE L 139 -1 O LEU L 135 N THR L 116 SHEET 3 AB1 4 TYR L 172 LEU L 180 -1 O ALA L 174 N ILE L 136 SHEET 4 AB1 4 VAL L 159 THR L 161 -1 N GLU L 160 O TYR L 177 SHEET 1 AB2 4 SER L 114 PHE L 118 0 SHEET 2 AB2 4 ALA L 130 PHE L 139 -1 O LEU L 135 N THR L 116 SHEET 3 AB2 4 TYR L 172 LEU L 180 -1 O ALA L 174 N ILE L 136 SHEET 4 AB2 4 SER L 165 LYS L 166 -1 N SER L 165 O ALA L 173 SHEET 1 AB3 4 SER L 153 VAL L 155 0 SHEET 2 AB3 4 THR L 145 ALA L 150 -1 N ALA L 150 O SER L 153 SHEET 3 AB3 4 TYR L 191 HIS L 197 -1 O GLN L 194 N ALA L 147 SHEET 4 AB3 4 SER L 200 VAL L 206 -1 O SER L 200 N HIS L 197 SHEET 1 AB4 5 GLY C 39 VAL C 42 0 SHEET 2 AB4 5 VAL C 45 ALA C 48 -1 O VAL C 47 N LEU C 40 SHEET 3 AB4 5 VAL C 83 ALA C 92 1 O PHE C 89 N ALA C 48 SHEET 4 AB4 5 ALA C 61 PHE C 73 -1 N SER C 63 O MET C 90 SHEET 5 AB4 5 VAL C 151 HIS C 153 1 O ARG C 152 N ILE C 66 SSBOND 1 CYS H 22 CYS H 92 1555 1555 2.04 SSBOND 2 CYS H 152 CYS H 208 1555 1555 2.03 SSBOND 3 CYS L 22 CYS L 87 1555 1555 2.04 SSBOND 4 CYS L 134 CYS L 193 1555 1555 2.03 CISPEP 1 PHE H 158 PRO H 159 0 -3.41 CISPEP 2 GLU H 160 PRO H 161 0 0.07 CISPEP 3 TYR L 140 PRO L 141 0 0.35 CRYST1 69.599 85.218 175.432 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014368 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011735 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005700 0.00000